補(bǔ)體1q(C1q)多克隆抗體
Polyclonal Antibody to Complement 1q (C1q)
C1-q; Autoantigen Clq
- 編號(hào)PAA747Hu01
- 物種Homo sapiens (Human，人) 相同的名稱(chēng)，不同的物種。
- 來(lái)源多抗制備
- 宿主兔
- 效價(jià)-
- Ig類(lèi)型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 免疫原 -
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種-
- 應(yīng)用WB; IHC; ICC; IP.
如果抗體需用于流式細(xì)胞術(shù)，請(qǐng)參見(jiàn)流式抗體。 - 下載 英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 644 ¥ 1504 ¥ 2148 ¥ 5370 ¥ 21480
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Vector Red staining on IHC-P; Samples: Human Liver Tissue; Primary Ab: 20μg/ml Rabbit Anti-Human C1qA Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
-
通過(guò)ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對(duì)C1q的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別C1q。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過(guò)兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲(chǔ)，損失率低于5%。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| PAA747Hu01 | 補(bǔ)體1q(C1q)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA747Hu71 | 補(bǔ)體1q(C1q)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| SEA747Hu | 補(bǔ)體1q(C1q)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| AEA747Hu | 抗補(bǔ)體1q抗體(Anti-C1q)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
| LMA747Hu | 補(bǔ)體1q(C1q)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSA747Hu01 | 補(bǔ)體1q(C1q)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of Clinical Immunology | Complement activation contributes to the injury and outcome of kidney in human anti-glomerular basement membrane disease. [PubMed: 22941511] |
| Fish and Shellfish Immunology | Characterization of complement 1q binding protein of tiger shrimp, Penaeus monodon, and its C1q binding activity [Pubmed: 23085472] |
| Journal of Neuroimmunology | Acute and prolonged complement activation in the central nervous system during herpes simplex encephalitis [Pubmed:27235358] |
| Archives of Gynecology and Obstetrics | The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis [Pubmed:29572748] |
| Journal of?NeuroVirology | Intrathecal complement activation by the classical pathway in tick-borne encephalitis [Pubmed: 30850976] |
| PLoS One | Complement activation profile of patients with primary focal segmental glomerulosclerosis [Pubmed: 32569286] |
| CELL | Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia [33248023] |
| Chinese Journal of Nephrology, Dialysis & Transplantation | Plasma and urine complement activation products in light chain and heavy chain deposition disease [] |
| Journal of Chemical Neuroanatomy | Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity [34280490] |
| Neuropsychiatr Dis Treat | Elevated Serum Complement C1q Levels After Traumatic Brain Injury and Its Association with Poor Prognosis [Pubmed:35035218] |
留言咨詢(xún)
